Kinnate Biopharma Inc. Provides Corporate Update and Highlights Key Upcoming 2022 Milestones

NEXT STORY
Immuneering Reports Compelling Preclinical Data on IMM-1-104 in NRAS Mutant Melanoma Model And Will Host Key External Expert Investor Event
PREV STORY
TransCode Therapeutics To Participate at H.C. Wainwright BioConnect Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Generex Biotechnology Announces Call-in Details and Updated Agenda for Shareholder Conference Call on Wednesday, August 26th, 2020 at 9:30 AM Eastern

author_avatar
NASDAQ Market News

1Life Healthcare (One Medical) Announces Pricing of $275 Million of Convertible Senior Notes Due 2025

author_avatar
NASDAQ Market News

VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study in Patients with Recurrent Glioblastoma

Conference Call and Webcast @ 8:30am ET Today TEL AVIV, Israel, March 08, 2018 ...

author_avatar
NASDAQ Market News